Continue on TOI App
Open App
OPEN APP

Russian tennis player faces multi-year suspension after testing positive for prohibited substance

Russian tennis player Daniil Savelev has been given a two-year su... Read More
NEW DELHI: Russian tennis player Daniil Savelev has been handed a two-year suspension for violating anti-doping regulations.

Tired of too many ads?go ad free now
The International Tennis Integrity Agency (ITIA) announced on Friday that Savelev tested positive for the prohibited substance meldonium during a test conducted in July 2024.

Consequently, he has been provisionally suspended since August of the same year, and his suspension will conclude in August 2026.

At the time of the violation, Savelev had achieved a career-high world doubles ranking of 1,486 in August 2022.


The ITIA stated that while they believe Savelev did not intentionally ingest the banned substance, he admitted to consuming meldonium tablets, mistaking them for supplements due to their similar appearance within his family's medication.

Tired of too many ads?go ad free now
“Savelev admitted to ingesting meldonium tablets, confusing family medication for supplements of a similar appearance,” ITIA expailned.

Despite acknowledging the unintentional nature of the violation, the ITIA emphasized that Savelev did not take any mitigating steps to address the rules infringement.

As a result, he agreed to accept the two-year suspension imposed by the anti-doping authorities.

It is important to note that the ITIA's decision underscores the strict adherence to anti-doping regulations in professional tennis, regardless of the circumstances surrounding the violation.

Athletes are responsible for ensuring they do not consume prohibited substances, whether intentionally or unintentionally.
About the Author

TOI Sports Desk

The TOI Sports Desk excels in a myriad of roles that capture the ... Read More

Start a Conversation

Post comment
Continue Reading
Follow Us On Social Media
end of article
More Trending Stories
Visual Stories
More Visual Stories
UP NEXT
Do Not Sell Or Share My Personal Information